Artelo Biosciences, Inc. (ARTL)

NASDAQ: ARTL · Delayed Price · USD
0.394
-0.031 (-7.22%)
At close: Jan 21, 2022 4:00 PM
0.390
-0.004 (-1.116%)
After-hours:Jan 21, 2022 5:40 PM EST
Market Cap16.68M
Revenue (ttm)n/a
Net Income (ttm)-8.55M
Shares Out42.30M
EPS (ttm)-0.36
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume685,229
Open0.401
Previous Close0.425
Day's Range0.380 - 0.420
52-Week Range0.380 - 3.670
Beta1.26
AnalystsBuy
Price Target4.67 (+1,084.1%)
Earnings Daten/a

About ARTL

Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and post-traumatic stress disorder (PTSD); and ART26.12, a fatty acid binding protein 5 inhibitor for pr...

IndustryPharmaceuticals
Founded2011
Employees4
Stock ExchangeNASDAQ
Ticker SymbolARTL
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to 3 analysts, the average rating for ARTL stock is "Buy." The 12-month stock price forecast is 4.67, which is an increase of 1,084.08% from the latest price.

Price Target
$4.67
(1,084.08% upside)
Analyst Consensus: Buy

News

Artelo Biosciences Reports First Quarter Fiscal Year 2022 Financial Results and Provides Business Update

Complete Enrollment of Phase 1 CAReS Trial Anticipated by End of First Quarter of Calendar Year 2022

1 week ago - GlobeNewsWire

Artelo Anticipates Accelerated Clinical Development for ART27.13 Following Its Classification Change in the United Ki...

SOLANA BEACH, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL) announced that the United Kingdom's Home Office has classified the Company's lead clinical cannabinoid, AR...

1 week ago - GlobeNewsWire

Artelo Biosciences Leadership to Participate on Endocannabinoid Panel at the H.C. Wainwright BioConnect 2022 Virtual ...

Artelo CEO also providing corporate outlook for 2022 at the H.C. Wainwright Conference Artelo CEO also providing corporate outlook for 2022 at the H.C. Wainwright Conference

1 week ago - GlobeNewsWire

Is Artelo Biosciences, Inc. (ARTL) Stock Outpacing Its Medical Peers This Year?

Here is how Artelo Biosciences, Inc. (ARTL) and Avalo Therapeutics, Inc. (AVTX) have performed compared to their sector so far this year.

2 weeks ago - Zacks Investment Research

Artelo Biosciences Reports Fiscal 2021 Year-End Financial Results and Provides Business Update

$26.8 Million in Cash and Marketable Securities as of November 15, 2021, Expected to Support Operations Well Into 2023 $26.8 Million in Cash and Marketable Securities as of November 15, 2021, Expected t...

1 month ago - GlobeNewsWire

Artelo Biosciences to Present at the Q4 Investor Summit on November 17th

Solana Beach, California--(Newsfile Corp. - November 11, 2021) - Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage pharmaceutical company developing therapeutics that modulate endogenous signali...

2 months ago - Newsfile Corp

Best Penny Stocks to Watch in Mid-November 2021

Are these penny stocks on your watchlist this week? The post Best Penny Stocks to Watch in Mid-November 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Other symbols:BAOSSENS
2 months ago - PennyStocks

Are These Trending Penny Stocks Worth Buying at Current Levels?

Check these trending penny stocks out for your watchlist The post Are These Trending Penny Stocks Worth Buying at Current Levels? appeared first on Penny Stocks to Buy, Picks, News and Information | Pen...

Other symbols:CNCEPETZ
2 months ago - PennyStocks

Hot Reddit Penny Stocks to Watch That Exploded Today

Check these Reddit penny stocks out for your watchlist in November The post Hot Reddit Penny Stocks to Watch That Exploded Today appeared first on Penny Stocks to Buy, Picks, News and Information | Penn...

Other symbols:ABVCFAMI
2 months ago - PennyStocks

Artelo Biosciences to Present at the Q3 Virtual Investor Summit on August 18th

Solana Beach, California--(Newsfile Corp. - August 11, 2021) - Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company focused on the development of therapeutics that target ...

5 months ago - Newsfile Corp

Artelo Biosciences Announces Publication of Study Results Comparing the Pharmacological Effects of Plant-Derived Vers...

Study finds no in-vitro pharmacological difference in the antiproliferative, anti-inflammatory, or permeability effects of purified natural versus synthetic CBD

5 months ago - GlobeNewsWire

Ladenburg Thalmann to Host R&D Showcase Featuring Artelo Biosciences' CAReS Study on July 28, 2021

LA JOLLA, Calif., July 21, 2021 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL ), a clinical stage biopharmaceutical company focused on the development of therapeutics that target lipid sign...

6 months ago - GlobeNewsWire

Artelo Biosciences Reports Third Quarter Fiscal 2021 Financial Results and Provides Business Update

Enrollment in CAReS Study in patients with cancer anorexia on track to deliver first data readout by calendar year-end

6 months ago - GlobeNewsWire

Artelo Biosciences Announces Two Poster Presentations Featured at the 31st Annual ICRS Symposium

Dr. Andrew Yates to Present Poster on the Company's ART27.13 Cancer Appetite Recovery Study

6 months ago - GlobeNewsWire

Artelo Biosciences to Present at the LD Micro Virtual Invitational XI on June 9th

LA JOLLA, Calif., June 02, 2021 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL ), a clinical stage biopharmaceutical company focused on the development of therapeutics that modulate endogeno...

7 months ago - GlobeNewsWire

Artelo Biosciences Reports Second Quarter Fiscal 2021 Financial Results and Provides Business Update

Recently Commenced Patient Enrollment in Phase 1/2 CAReS Study of ART27.13 in the UK

9 months ago - GlobeNewsWire

Artelo Biosciences Doses First Patient in CAReS Study with ART27.13 for the Treatment of Cancer-Related Anorexia and ...

Initial safety data expected from CAReS Study before end of 2021

9 months ago - GlobeNewsWire

Artelo Biosciences Accepted into the Alderley Park Oncology Development Program for FABP5 Inhibitor Biomarker Develop...

Detection of elevated FABP5 associated with additional tumor types suggests  the target for ART26.12 may be more broadly relevant in cancer therapy

10 months ago - GlobeNewsWire

Artelo Biosciences, Inc. to Present at the Q1 Virtual Investor Summit on March 23rd

LA JOLLA, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company developing therapeutics that modulate lipid-si...

10 months ago - GlobeNewsWire

Artelo Biosciences Appoints Finance and Healthcare Industry Executive Tamara A. Seymour to Board of Directors

LA JOLLA, Calif., March 09, 2021 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL ), a clinical stage biopharmaceutical company focused on the development of therapeutics that target lipid-sig...

10 months ago - GlobeNewsWire

Artelo Biosciences to Present at the H.C. Wainwright Global Life Sciences Conference on March 9th

LA JOLLA, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company developing therapeutics that modulate endogenous signaling pathwa...

10 months ago - GlobeNewsWire

Artelo Biosciences Announces Positive Pre-Clinical Data Associated with Proprietary CBD Cocrystal

Research demonstrates co-administration of CBD and TMP could confer ART12.11 with a more desirable pharmacodynamic profile Research demonstrates co-administration of CBD and TMP could confer ART12.11 wi...

11 months ago - GlobeNewsWire

ARTL Stock Alert: The Big Reason Biopharma Artelo Biosciences Is Rocketing Today

Artelo Biosciences (ARTL) stock is soaring higher on Friday after Ladenburg analyst Michael Higgins initiated coverage of the company. The post ARTL Stock Alert: The Big Reason Biopharma Artelo Bioscien...

11 months ago - InvestorPlace

Artelo Biosciences Receives $3.0 Million in Net Proceeds from Exercise of Warrants

LA JOLLA, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company developing therapeutics that modulate endogenous signaling pathway...

11 months ago - GlobeNewsWire

Artelo Biosciences Announces Research Collaboration with Trinity College Dublin to Investigate ART27.13 for the Treat...

LA JOLLA, Calif., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc.  (NASDAQ:  ARTL ) today embarks on a collaboration with researchers from Trinity College Dublin to investigate pre-clinical m...

11 months ago - GlobeNewsWire